{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:42:47Z","timestamp":1793241767043,"version":"4.5.0"},"reference-count":122,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>CD147 also known as EMMPRIN, basigin, and HAb18G, is a single-chain type I transmembrane protein shown to be overexpressed in aggressive human cancers of CNS, head and neck, breasts, lungs, gastrointestinal, genitourinary, skin, hematological, and musculoskeletal. In these malignancies, the molecule is integral to the diverse but complimentary hallmarks of cancer: it is pivotal in cancerous proliferative signaling, growth propagation, cellular survival, replicative immortality, angiogenesis, metabolic reprogramming, immune evasion, invasion, and metastasis. CD147 also has regulatory functions in cancer-enabling characteristics such as DNA damage response (DDR) and immune evasion. These neoplastic functions of CD147 are executed through numerous and sometimes overlapping molecular pathways: it transduces signals from upstream molecules or ligands such as cyclophilin A (CyPA), CD98, and S100A9; activates a repertoire of downstream molecules and pathways including matrix metalloproteinases (MMPs)-2,3,9, hypoxia-inducible factors (HIF)-1\/2\u03b1, PI3K\/Akt\/mTOR\/HIF-1\u03b1, and ATM\/ATR\/p53; and also functions as an indispensable chaperone or regulator to monocarboxylate, fatty acid, and amino acid transporters. Interestingly, induced loss of functions to CD147 prevents and reverses the acquired hallmarks of cancer in neoplastic diseases. Silencing of Cd147 also alleviates known resistance to chemoradiotherapy exhibited by malignant tumors like carcinomas of the breast, lung, pancreas, liver, gastric, colon, ovary, cervix, prostate, urinary bladder, glioblastoma, and melanoma. Targeting CD147 antigen in chimeric and induced-chimeric antigen T cell or antibody therapies is also shown to be safer and more effective. Moreover, incorporating anti-CD147 monoclonal antibodies in chemoradiotherapy, oncolytic viral therapy, and oncolytic virus-based-gene therapies increases effectiveness and reduces on and off-target toxicity. This study advocates the expedition and expansion by further exploiting the evidence acquired from the experimental studies that modulate CD147 functions in hallmarks of cancer and cancer-enabling features and strive to translate them into clinical practice to alleviate the emergency and propagation of cancer, as well as the associated clinical and social consequences.<\/jats:p>","DOI":"10.3389\/fonc.2023.1238051","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T08:24:11Z","timestamp":1699345451000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":57,"title":["CD147: an integral and potential molecule to abrogate hallmarks of cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Alphonce M. K.","family":"Nyalali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela U.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibera K.","family":"Rugambwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.cell.2021.03.009","article-title":"Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes","volume":"184","author":"Dentro","year":"2021","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.72534","article-title":"Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance","volume":"18","author":"Zhang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"200358","DOI":"10.1098\/rsob.200358","article-title":"Hallmarks of cancer-the new testament","volume":"11","author":"Senga","year":"2021","journal-title":"Open Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2018.09.008","article-title":"Identification and analyses of natural compounds as potential inhibitors of TRAF6-Basigin interactions in melanoma using structure-based virtual screening and molecular dynamics simulations","volume":"85","author":"Biswas","year":"2018","journal-title":"J Mol Graph Model"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111803","article-title":"CD147 is a promising target of tumor progression and a prognostic biomarker","volume":"11","author":"Landras","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2007.08.014","article-title":"CD147 immunoglobulin superfamily receptor function and role in pathology","volume":"83","author":"Iacono","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.149.3.847","article-title":"Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule","volume":"149","author":"Kasinrerk","year":"1992","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-802918","article-title":"Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion by Plasmodium falciparum","volume":"131","author":"Zhang","year":"2018","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nature13715","article-title":"Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies","volume":"515","author":"Wright","year":"2014","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-021-00603-6","article-title":"Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial","volume":"6","author":"Bian","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.111583198","article-title":"CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A","volume":"98","author":"Pushkarsky","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2004.09.023","article-title":"EMMPRIN\/CD147, an MMP modulator in cancer, development and tissue repair","volume":"87","author":"Gabison","year":"2005","journal-title":"Biochimie"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11060-013-1207-2","article-title":"Prognostic significance of CD147 in patients with glioblastoma","volume":"115","author":"Yang","year":"2013","journal-title":"J Neurooncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-013-9720-3","article-title":"Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and its correlation with poor prognosis","volume":"20","author":"Gou","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2013.02.015","article-title":"Expression of HAb18G\/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer","volume":"209","author":"Xu","year":"2013","journal-title":"Pathol Res Pract"},{"key":"B20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12032-012-0335-4","article-title":"High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients","volume":"30","author":"Zhao","year":"2013","journal-title":"Med Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.5.7.2754","article-title":"CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients","volume":"5","author":"Zhang","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.07.042","article-title":"HAb18G\/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis","volume":"57","author":"Zhang","year":"2012","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101027","article-title":"CD147 expression in human gastric cancer is associated with tumor recurrence and prognosis","volume":"9","author":"Chu","year":"2014","journal-title":"PloS One"},{"key":"B24","article-title":"Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer","volume":"7","author":"Kaira","year":"2015","journal-title":"Am J Transl Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12032-012-0369-7","article-title":"EMMPRIN\/CD147 expression is associated with disease-free survival of patients with colorectal cancer","volume":"30","author":"Zhu","year":"2013","journal-title":"Med Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/1479-5876-11-258","article-title":"Renal cell neoplasias: reversion-inducing cysteine-rich protein with Kazal motifs discriminates tumor subtypes, while extracellular matrix metalloproteinase inducer indicates prognosis","volume":"11","author":"Rabien","year":"2013","journal-title":"J Transl Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-010-9582-4","article-title":"CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer","volume":"28","author":"Xue","year":"2011","journal-title":"Med Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25982","article-title":"Expression of CD147 is associated with prostate cancer progression","volume":"130","author":"Zhong","year":"2012","journal-title":"Int J Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2019.4103","article-title":"Co\u2212expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with Malignant progression and poor prognosis","volume":"43","author":"Liu","year":"2019","journal-title":"Int J Mol Med"},{"key":"B30","article-title":"CD147 promotes cervical cancer migration and invasion by up-regulating fatty acid synthase expression","volume":"12","author":"Guo","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10390","article-title":"Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts","volume":"99","author":"Kanekura","year":"2002","journal-title":"Int J Cancer."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2012.981","article-title":"Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN\/CD147, in human osteosarcoma","volume":"5","author":"Lu","year":"2013","journal-title":"Oncol Lett"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyq098","article-title":"CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia","volume":"40","author":"Fu","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13996","article-title":"CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling","volume":"23","author":"Yu","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.543856","article-title":"Detachment activated cyPA\/CD147 induces cancer stem cell potential in non-stem breast cancer cells","volume":"8","author":"Meng","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1010428317695927","DOI":"10.1177\/1010428317695927","article-title":"The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147(+) breast cancer stem cells","volume":"39","author":"Lv","year":"2017","journal-title":"Tumour Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3816-1","article-title":"CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K\/Akt signaling pathway","volume":"21","author":"Fei","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-014-9536-6","article-title":"Upregulation of CD147 protects hepatocellular carcinoma cell from apoptosis through glycolytic switch via HIF-1 and MCT-4 under hypoxia","volume":"8","author":"Ke","year":"2014","journal-title":"Hepatol Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.4.7.1828","article-title":"Inhibition of basigin expression in glioblastoma cell line via antisense RNA reduces tumor cell invasion and angiogenesis","volume":"4","author":"Liang","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s10735-020-09946-w","article-title":"miR-4319 inhibited retinoblastoma cells proliferation, migration, invasion and EMT progress via suppressing CD147 mediated MMPs expression","volume":"52","author":"Wu","year":"2021","journal-title":"J Mol Histol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.07.039","article-title":"CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt\/mTOR\/SREBP1c and P38\/PPAR\u03b1 pathways","volume":"63","author":"Li","year":"2015","journal-title":"J Hepatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143377","article-title":"Glucose deprivation-induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma","volume":"131","author":"Loong","year":"2021","journal-title":"J Clin Invest"},{"key":"B43","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cell.2020.11.043","article-title":"Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates","volume":"184","author":"Wang","year":"2021","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0621","article-title":"HAb18G\/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s","volume":"19","author":"Li","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14272","article-title":"CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming","volume":"8","author":"Kendrick","year":"2017","journal-title":"Oncotarget"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1177\/1535370213493706","article-title":"ERK1\/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion","volume":"238","author":"Chen","year":"2013","journal-title":"Exp Biol Med (Maywood)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.06.122","article-title":"Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism","volume":"374","author":"Baba","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B48","article-title":"Extracellular matrix metalloproteinase inducer (CD147\/BSG\/EMMPRIN)-induced radioresistance in cervical cancer by regulating the percentage of the cells in the G2\/m phase of the cell cycle and the repair of DNA Double-strand Breaks (DSBs)","volume":"8","author":"Ju","year":"2016","journal-title":"Am J Transl Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-010-9345-9","article-title":"Co-expression of CD147\/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression","volume":"27","author":"Chen","year":"2010","journal-title":"Clin Exp Metastasis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.2849","article-title":"CD147 modulates autophagy through the PI3K\/Akt\/mTOR pathway in human prostate cancer PC-3 cells","volume":"9","author":"Fang","year":"2015","journal-title":"Oncol Lett"},{"key":"B51","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.semcancer.2015.02.006","article-title":"Sustained proliferation in cancer: Mechanisms and novel therapeutic targets","author":"Feitelson","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cels.2016.01.001","article-title":"A dynamical framework for the all-or-none G1\/S transition","volume":"2","author":"Barr","year":"2016","journal-title":"Cell Syst"},{"key":"B53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat Rev Cancer."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2691-5","article-title":"Secreted cyclophilin A mediates G1\/S phase transition of cholangiocarcinoma cells via CD147\/ERK1\/2 pathway","volume":"36","author":"Obchoei","year":"2015","journal-title":"Tumour Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J BioMed Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2428","article-title":"Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model","volume":"14","author":"Xia","year":"2012","journal-title":"Nat Cell Biol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ar.21489","article-title":"Suppression of oxLDL-induced MMP-9 and EMMPRIN expression by berberine via inhibition of NF-\u03baB activation in human THP-1 macrophages","volume":"295","author":"Huang","year":"2012","journal-title":"Anat Rec (Hoboken)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-016-2727-2","article-title":"The effects of CD147 on the cell proliferation, apoptosis, invasion, and angiogenesis in glioma","volume":"38","author":"Yin","year":"2017","journal-title":"Neurol Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3455","article-title":"Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases","volume":"10","author":"Carmeliet","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"B64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41389-017-0011-9","article-title":"The hypoxic tumour microenvironment","volume":"7","author":"Petrova","year":"2018","journal-title":"Oncogenesis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2021.10.004","article-title":"Revisiting the HIF switch in the tumor and its immune microenvironment","volume":"8","author":"Cowman","year":"2022","journal-title":"Trends Cancer."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012265","article-title":"EMMPRIN promotes melanoma cells Malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2","volume":"5","author":"Bougatef","year":"2010","journal-title":"PloS One"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/art.34341","article-title":"CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1\u03b1-mediated pathway in rheumatoid arthritis","volume":"64","author":"Wang","year":"2012","journal-title":"Arthritis Rheumatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603425","article-title":"Upregulated EMMPRIN\/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis","volume":"95","author":"Zheng","year":"2006","journal-title":"Br J Cancer"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.07.009","article-title":"PI3K\/Akt\/mTOR inhibitors in cancer: At the bench and bedside","volume":"59","author":"Alzahrani","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137552","article-title":"HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer","volume":"130","author":"de Heer","year":"2020","journal-title":"J Clin Invest."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/jcr.1925.148","article-title":"The metabolism of carcinoma cells","volume":"9","author":"Warburg","year":"1925","journal-title":"J Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1042\/bj0230536","article-title":"Observations on the carbohydrate metabolism of tumours","volume":"23","author":"Crabtree","year":"1929","journal-title":"Biochem J"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1101\/gad.189365.112","article-title":"Links between metabolism and cancer","volume":"26","author":"Dang","year":"2012","journal-title":"Genes Dev"},{"key":"B76","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1038\/s41598-017-04612-w","article-title":"Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression","volume":"7","author":"Voss","year":"2017","journal-title":"Sci Rep"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2005.04.005","article-title":"Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime","volume":"15","author":"Fuchs","year":"2005","journal-title":"Semin Cancer Biol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0685-0","article-title":"CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases","volume":"16","author":"Kaira","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2115","article-title":"Downregulation of CD147 by chitooligosaccharide inhibits MMP-2 expression and suppresses the metastatic potential of human gastric cancer","volume":"8","author":"Luo","year":"2014","journal-title":"Oncol Lett"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.3748","article-title":"Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2\/MMP\u22129 via the ERK signaling pathway","volume":"33","author":"Yang","year":"2015","journal-title":"Oncol Rep"},{"key":"B81","article-title":"BetaIg-h3 is involved in the HAb18G\/CD147-mediated metastasis process in human hepatoma cells","volume":"232","author":"Tang","year":"2007","journal-title":"Exp Biol Med (Maywood)."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00155","article-title":"Implications of the hybrid epithelial\/mesenchymal phenotype in metastasis","volume":"5","author":"Jolly","year":"2015","journal-title":"Front Oncol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/nature10760","article-title":"The DNA damage response and cancer therapy","volume":"481","author":"Lord","year":"2012","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.7.1703","article-title":"Homologous and non-homologous recombination differentially affect DNA damage repair in mice","volume":"19","author":"Essers","year":"2000","journal-title":"EMBO J"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2020.10.006","article-title":"Fluorescence sheds light on DNA damage, DNA repair, and mutations","volume":"7","author":"Owiti","year":"2021","journal-title":"Trends Cancer"},{"key":"B86","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bbrc.2020.05.005","article-title":"CD147 promotes DNA damage response and gemcitabine resistance via targeting ATM\/ATR\/p53 and affects prognosis in pancreatic cancer","volume":"528","author":"Zhou","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B87","article-title":"CD147\u2212mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review)","volume":"41","author":"Li","year":"2019","journal-title":"Oncol Rep"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41423-020-00570-y","article-title":"CD147 regulates antitumor CD8(+) T-cell responses to facilitate tumor-immune escape","volume":"18","author":"Chen","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.60894","article-title":"CD147 confers temozolomide resistance of glioma cells via the regulation of \u03b2-TrCP\/Nrf2 pathway","volume":"17","author":"Bu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22222","article-title":"CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance","volume":"54","author":"Afonso","year":"2015","journal-title":"Mol Carcinog"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-015-2397-z","article-title":"MiR-492 is functionally involved in Oxaliplatin resistance in colon cancer cells LS174T via its regulating the expression of CD147","volume":"405","author":"Peng","year":"2015","journal-title":"Mol Cell Biochem"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2862","article-title":"Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status","volume":"6","author":"Granja","year":"2015","journal-title":"Oncotarget"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2012.60","article-title":"CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma","volume":"19","author":"Tang","year":"2012","journal-title":"Cell Death Differ"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.07.005","article-title":"Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells","volume":"248","author":"Zou","year":"2007","journal-title":"Cancer Lett"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8199","article-title":"Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H(+)-ATPase expression and activity","volume":"15","author":"Kuang","year":"2018","journal-title":"Oncol Lett"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605839","article-title":"Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression","volume":"103","author":"Hao","year":"2010","journal-title":"Br J Cancer"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2014.02.021","article-title":"Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor","volume":"190","author":"Zeiderman","year":"2014","journal-title":"J Surg Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.14670\/HH-11-863","article-title":"GLUT1, MCT1\/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma","volume":"32","author":"Almeida","year":"2017","journal-title":"Histol Histopathol."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.2174\/1566524014666141202144601","article-title":"CD147 interacts with NDUFS6 in regulating mitochondrial complex I activity and the mitochondrial apoptotic pathway in human Malignant melanoma cells","volume":"14","author":"Luo","year":"2014","journal-title":"Curr Mol Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1038\/s41467-020-18444-2","article-title":"Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma","volume":"11","author":"Tseng","year":"2020","journal-title":"Nat Commun"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00233","article-title":"Doxycycline inducible chimeric antigen receptor T cells targeting CD147 for hepatocellular carcinoma therapy","volume":"7","author":"Zhang","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/15384047.2016.1276126","article-title":"Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma","volume":"18","author":"Feng","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"B103","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10585-014-9689-7","article-title":"A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway","volume":"32","author":"Wang","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/cbr.2016.2126","article-title":"Downregulation of extracellular matrix metalloproteinase inducer by scFv-M6-1B9 intrabody suppresses cervical cancer invasion through inhibition of urokinase-type plasminogen activator","volume":"32","author":"Panich","year":"2017","journal-title":"Cancer Biother Radiopharm"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.12.034","article-title":"Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I\/II trials","volume":"65","author":"Chen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B106","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13046-015-0271-1","article-title":"Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice","volume":"34","author":"Wei","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023274","article-title":"hSulf-1 gene exhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers","volume":"6","author":"Ji","year":"2011","journal-title":"PloS One"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19102979","article-title":"Efficacy evaluation of combination treatment using gemcitabine and radioimmunotherapy with (90)Y-labeled fully human anti-CD147 monoclonal antibody 059-053 in a bxPC-3 xenograft mouse model of refractory pancreatic cancer","volume":"19","author":"Sugyo","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2017.09.012","article-title":"Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes","volume":"14","author":"Wang","year":"2018","journal-title":"Nanomedicine"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30422-4","article-title":"Adjuvant (131)I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial","volume":"5","author":"Li","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0104","article-title":"Preclinical pharmacokinetics, tolerability, and pharmacodynamics of metuzumab, a novel CD147 human-mouse chimeric and glycoengineered antibody","volume":"14","author":"Zhang","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.04.046","article-title":"A novel antibody-drug conjugate, HcHAb18-DM1, has potent anti-tumor activity against human non-small cell lung cancer","volume":"513","author":"Huhe","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B113","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1208\/s12248-012-9386-x","article-title":"ADME of antibody-maytansinoid conjugates","volume":"14","author":"Erickson","year":"2012","journal-title":"AAPS J"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1038\/s41467-019-11137-5","article-title":"Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy","volume":"10","author":"Niemann","year":"2019","journal-title":"Nat Commun"},{"key":"B116","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.1038\/s41467-019-12794-2","article-title":"Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy","volume":"10","author":"Huang","year":"2019","journal-title":"Nat Commun"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2012.10.007","article-title":"An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma","volume":"7","author":"Zhang","year":"2013","journal-title":"Mol Oncol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40425-018-0458-z","article-title":"Oncolytic virus immunotherapy: future prospects for oncology","volume":"6","author":"Raja","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000330","article-title":"A recombinant oncolytic Newcastle virus expressing MIP-3\u03b1 promotes systemic antitumor immunity","volume":"8","author":"Huang","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2011.10.001","article-title":"Inhibitory effect of Survivin promoter-regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer","volume":"5","author":"Liu","year":"2011","journal-title":"Mol Oncol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-011-0491-5","article-title":"(18)F-FDG PET\/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts","volume":"14","author":"Shah","year":"2012","journal-title":"Mol Imaging Biol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/nature13283","article-title":"The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation","volume":"511","author":"Zahreddine","year":"2014","journal-title":"Nature"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1238051\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T08:24:25Z","timestamp":1699345465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1238051\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":122,"alternative-id":["10.3389\/fonc.2023.1238051"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1238051","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]},"article-number":"1238051"}}